Shenzhen Bailey Times Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Bailey Times Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 12 (Vehicles) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DRIMZOVAX. The owner is based in Guangdong province.

Room 405, No. 190, Ainan Road, Nanlian Community

Longgang Street, Longgang District, Shenzhen City

Guangdong province 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DRIMZOVAX
DRIMZOVAX
Registered 2025

Trademark Classifications

Shenzhen Bailey Times Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Shenzhen Bailey Times Technology Co., Ltd. have?

Shenzhen Bailey Times Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Bailey Times Technology Co., Ltd. file in?

Shenzhen Bailey Times Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 12 (Vehicles). Class 12 covers vehicles; apparatus for locomotion by land, air or water.

What are Shenzhen Bailey Times Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Bailey Times Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as DRIMZOVAX. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Bailey Times Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Bailey Times Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.